The global coronavirus pandemic requires a global response. The world quickly needs to develop and deploy effective diagnostics, treatments and a vaccine. Without them, every country in the world remains vulnerable. Countries and organisations around the world are joining forces to ensure that not only do we develop these life-saving tools but that we ensure they are universally available and affordable. No person, country or region should be left behind.
Grounded in a vision of a planet protected from human suffering and the devastating social and economic consequences of COVID-19, an initial group of global health actors has launched a landmark, global collaboration for the accelerated development, production and equitable global access to new COVID-19 essential health technologies. Read their call to action here.
The European Union and its partners are hosting an international pledging conference starting on Monday 4 May 2020 where we aim to raise €7.5 billion in initial funding to kick-start the global cooperation.
World-leading scientists and health experts, gathered in the Global Preparedness Monitoring Board – co-convened by the WHO and the World Bank – say €7.5 billion ($8 billion) represents the immediate needs for developing solutions to test, treat and protect people, and to prevent the disease from spreading. With the Coronavirus Global Response Initiative, the EU and its partners are taking the lead in the global effort to close this funding gap.
Whether public or private organisations, companies or citizens, you can contribute by clicking HERE
More information on this international campaign HERE